142 related articles for article (PubMed ID: 21770036)
21. Preclinical study in cats of the pro-photosensitizer 5-aminolevulinic acid.
Lucroy MD; Edwards BF; Peavy GM; Krasieva TB; Griffey SM; Stiles JB; Madewell BR
Am J Vet Res; 1999 Nov; 60(11):1364-70. PubMed ID: 10566810
[TBL] [Abstract][Full Text] [Related]
22. The monitoring of the accumulation of protoporphyrin IX in Walker tumours by subcutaneous administration of delta-aminolevulinic acid.
Calin MA; Gruia Ml; Herascu N; Coman T
J Exp Ther Oncol; 2004 Oct; 4(3):247-51. PubMed ID: 15724844
[TBL] [Abstract][Full Text] [Related]
23. Dosimetry model for photodynamic therapy with topically administered photosensitizers.
Svaasand LO; Wyss P; Wyss MT; Tadir Y; Tromberg BJ; Berns MW
Lasers Surg Med; 1996; 18(2):139-49. PubMed ID: 8833282
[TBL] [Abstract][Full Text] [Related]
24. The temperature dependence of protoporphyrin IX production in cells and tissues.
Moan J; Berg K; Gadmar OB; Iani V; Ma L; Juzenas P
Photochem Photobiol; 1999 Oct; 70(4):669-73. PubMed ID: 10546563
[TBL] [Abstract][Full Text] [Related]
25. Topical hexylaminolevulinate and aminolevulinic acid photodynamic therapy: complete arteriole vasoconstriction occurs frequently and depends on protoporphyrin IX concentration in vessel wall.
Middelburg TA; de Bruijn HS; Tettero L; van der Ploeg van den Heuvel A; Neumann HA; de Haas ER; Robinson DJ
J Photochem Photobiol B; 2013 Sep; 126():26-32. PubMed ID: 23892187
[TBL] [Abstract][Full Text] [Related]
26. Topical 5-aminolevulinic acid-photodynamic therapy of hairless mouse skin using two-fold illumination schemes: PpIX fluorescence kinetics, photobleaching and biological effect.
Robinson DJ; de Bruijn HS; de Wolf WJ; Sterenborg HJ; Star WM
Photochem Photobiol; 2000 Dec; 72(6):794-802. PubMed ID: 11140268
[TBL] [Abstract][Full Text] [Related]
27. Effect of elevating the skin temperature during topical ALA application on in vitro ALA penetration through mouse skin and in vivo PpIX production in human skin.
van den Akker JT; Boot K; Vernon DI; Brown SB; Groenendijk L; van Rhoon GC; Sterenborg HJ
Photochem Photobiol Sci; 2004 Mar; 3(3):263-7. PubMed ID: 14993942
[TBL] [Abstract][Full Text] [Related]
28. A comparison of 5-aminolaevulinic acid- and its heptyl ester: dark cytotoxicity and protoporphyrin IX synthesis in human adenocarcinoma WiDr cells and in athymic nude mice healthy skin.
Pudroma X; Moan J; Ma LW; Iani V; Juzeniene A
Exp Dermatol; 2009 Nov; 18(11):985-7. PubMed ID: 19469901
[TBL] [Abstract][Full Text] [Related]
29. Kinetics of protoporphyrin IX formation in rat oral mucosa and skin after application of 5-aminolevulinic acid and its methylester.
Kristiansson S; Juzeniene A; Juzenas P; Iani V; Löfgren L; Moan J
Photochem Photobiol; 2005; 81(2):394-7. PubMed ID: 15535733
[TBL] [Abstract][Full Text] [Related]
30. A quantitative study of in vivo protoporphyrin IX fluorescence build up during occlusive treatment phases.
Campbell CL; Brown CTA; Wood K; Salvio AG; Inada NM; Bagnato VS; Moseley H
Photodiagnosis Photodyn Ther; 2017 Jun; 18():204-207. PubMed ID: 28257944
[TBL] [Abstract][Full Text] [Related]
31. Special article: measuring mitochondrial oxygen tension: from basic principles to application in humans.
Mik EG
Anesth Analg; 2013 Oct; 117(4):834-846. PubMed ID: 23592604
[TBL] [Abstract][Full Text] [Related]
32. Real-time, in vivo measurement of tissular pO2 through the delayed fluorescence of endogenous protoporphyrin IX during photodynamic therapy.
Piffaretti F; Novello AM; Kumar RS; Forte E; Paulou C; Nowak-Sliwinska P; van den Bergh H; Wagnières G
J Biomed Opt; 2012 Nov; 17(11):115007. PubMed ID: 23214178
[TBL] [Abstract][Full Text] [Related]
33. A HCl/alcohol formulation increased 5-aminolevulinic acid skin distribution using an ex vivo full thickness porcine skin model.
Maisch T; Worlicek C; Babilas P; Landthaler M; Szeimies RM
Exp Dermatol; 2008 Oct; 17(10):813-20. PubMed ID: 18380780
[TBL] [Abstract][Full Text] [Related]
34. Monitoring the accumulation and dissipation of the photosensitizer protoporphyrin IX during standard dermatological methyl-aminolevulinate photodynamic therapy utilizing non-invasive fluorescence imaging and quantification.
Tyrrell J; Campbell SM; Curnow A
Photodiagnosis Photodyn Ther; 2011 Mar; 8(1):30-8. PubMed ID: 21333932
[TBL] [Abstract][Full Text] [Related]
35. Targeting of sebaceous glands by δ-aminolevulinic acid-based photodynamic therapy: An in vivo study.
Kosaka S; Miyoshi N; Akilov OE; Hasan T; Kawana S
Lasers Surg Med; 2011 Jul; 43(5):376-81. PubMed ID: 21674542
[TBL] [Abstract][Full Text] [Related]
36. Topical application of 5-aminolevulinic acid, DMSO and EDTA: protoporphyrin IX accumulation in skin and tumours of mice.
Malik Z; Kostenich G; Roitman L; Ehrenberg B; Orenstein A
J Photochem Photobiol B; 1995 Jun; 28(3):213-8. PubMed ID: 7623186
[TBL] [Abstract][Full Text] [Related]
37. Topical application of 5-aminolaevulinic acid, methyl 5-aminolaevulinate and hexyl 5-aminolaevulinate on normal human skin.
Juzeniene A; Juzenas P; Ma LW; Iani V; Moan J
Br J Dermatol; 2006 Oct; 155(4):791-9. PubMed ID: 16965430
[TBL] [Abstract][Full Text] [Related]
38. Fluorescence spectroscopy of normal mouse skin exposed to 5-aminolaevulinic acid and red light.
Juzenas P; Iani V; Bagdonas S; Rotomskis R; Moan J
J Photochem Photobiol B; 2001 Aug; 61(1-2):78-86. PubMed ID: 11485851
[TBL] [Abstract][Full Text] [Related]
39. Demonstration of protoporphyrin IX (PpIX) localized to areas of palmar skin injected with 5-aminolevulinic acid (ALA) and pre-treated with a fractionated CO2 laser prior to topically applied ALA.
Letada PR; Shumaker PR; Uebelhoer NS
Photodiagnosis Photodyn Ther; 2010 Jun; 7(2):120-2. PubMed ID: 20510307
[TBL] [Abstract][Full Text] [Related]
40. Evidence for a bystander role of neutrophils in the response to systemic 5-aminolevulinic acid-based photodynamic therapy.
de Bruijn HS; Sluiter W; van der Ploeg-van den Heuvel A; Sterenborg HJ; Robinson DJ
Photodermatol Photoimmunol Photomed; 2006 Oct; 22(5):238-46. PubMed ID: 16948825
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
